AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,366.00p
   
  • Change Today:
    112.00p
  • 52 Week High: 13,276.00p
  • 52 Week Low: 9,725.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.62m
  • Volume: 1,006,644
  • Market Cap: £176,244m
  • RiskGrade: 123

Largest Deals (365 days)

Show trades greater than:
Traded Action Notifier PriceAmountValue
14-Nov-24 Buy Pascal Soriot 10,203.00p 20,000 £2,040,599.98
15-Nov-24 Buy Michel Demare 10,030.35p 2,000 £200,607.04
19-Nov-24 Buy Tony Mok 12,679.63p 1,500 £190,194.50
11-Nov-24 Buy Philip A J Broadley 10,169.91p 980 £99,665.11
13-Sep-24 Buy Michel Demare 117.93p 2,000 £2,358.55
06-Mar-25 Transfer From Pascal Soriot 0.000p 89,962 £0.00
05-Mar-25 Buy Dividends Pascal Soriot 0.000p 248 £0.00
05-Mar-25 Buy Dividends Aradhana Sarin 0.000p 28 £0.00
04-Mar-25 Transfer From Pascal Soriot 0.000p 17,357 £0.00
04-Mar-25 Transfer From Aradhana Sarin 0.000p 2,021 £0.00
10-Jun-24 Transfer To Pascal Soriot 0.000p 297,418 £0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,366.00p
Change Today 112.00p
% Change 1.00 %
52 Week High 13,276.00p
52 Week Low 9,725.00p
Volume 1,006,644
Shares Issued 1,550.62m
Market Cap £176,244m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.77% below the market average93.77% below the market average93.77% below the market average93.77% below the market average93.77% below the market average
79.17% below the sector average79.17% below the sector average79.17% below the sector average79.17% below the sector average79.17% below the sector average
Price Trend
37.51% above the market average37.51% above the market average37.51% above the market average37.51% above the market average37.51% above the market average
51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average
Income
67.16% below the market average67.16% below the market average67.16% below the market average67.16% below the market average67.16% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
85.66% above the market average85.66% above the market average85.66% above the market average85.66% above the market average85.66% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 15
Neutral 4
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 01-Apr-2025

Time Volume / Share Price
16:28 0 @ 11,360.00p
16:18 2 @ 11,364.00p
16:17 1 @ 11,368.00p
16:13 0 @ 11,380.00p
16:06 0 @ 11,376.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page